Background: Choroidal melanoma is a rare yet aggressive ocular malignancy, accounting for approximately 85% of all ocular melanomas. This study aimed to investigate the association between treatment ...

14 With reported prevalence rates from 0.2% to 30% in the white population, clinicians regularly face the challenge of differentiating common choroidal naevus from the much less common but potentially ...

Diagnosing rare diseases, such as choroid neoplasias, remains a critical challenge. Here, the authors develop a multimodal concept-based interpretable model (MMCBM) to distinguish uveal melanoma ...

in early-stage choroidal melanoma. Bel-sar is from a novel class of virus-like drug conjugate therapies that Boston, Massachusetts-based Aura is developing for various oncology indications.

An 81-year-old woman with good vision was followed up with the diagnosis of a minimally active melanoma. This tumour was eventually found to be a diffuse melanoma with extraocular extension. Diffuse ...

The primary offering of the company, bel-ser, is in the last stage of clinical development for the treatment of people living with choroidal melanoma. This small-cap company fully leverages its ...

He and his colleagues reported their experience with the Zap-X system in Cureus. 1 Uveal melanoma, which primarily affects Caucasian patients, is the most common primary intraocular tumor in adults 2 ...

It is important to understand the specific parts of the eye that are affected by metastatic uveal melanoma. The uveal tract is made up of three parts: Choroid -- the blood vessel-filled tissue ...

This is the official repository for A Concept-based Interpretable Model for the Diagnosis of Choroid Neoplasias using Multimodal Data This study introduces a multimodal concept-based interpretable ...

Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...